An observational study in Ophthalmic Imaging, Deep Learning and Artificial Intelligence (AI), sponsored by Second Affiliated Hospital of Nanchang University. Recruiting at 1 site in China. Open to participants aged 18 Years to 45 Years, including healthy volunteers. Per ClinicalTrials.gov, last updated 2026-11-20.
Sponsored by Second Affiliated Hospital of Nanchang University · Observational
Help build ClinicalTrials.gg — short surveys, remote interviews or testing, in your language. Take part →
To evaluate the diagnostic performance of a multimodal deep learning model for identifying biased Traditional Chinese Medicine (TCM) constitutions using ophthalmic imaging
The identification of Traditional Chinese Medicine (TCM) constitutions is a central principle of its preventive medicine philosophy (Zhi Wei Bing). Yet, current diagnostic methods-relying on subjective questionnaires and expert interpretation-are not scalable, objective, or efficient enough for widespread clinical use. While artificial intelligence has been applied to traditional inputs like tongue and pulse analysis, these approaches have failed to overcome fundamental issues of data standardization and objectivity. Consequently, a critical gap exists: there is no modern, reliable, and scalable tool to assess TCM constitutions, preventing the full integration of this valuable theory into contemporary healthcare.
This study aims to bridge that gap by developing and validating a novel deep learning model for "intelligent ocular diagnosis" of TCM constitutions. By using highly objective and information-rich ophthalmic imaging, our approach circumvents the subjectivity inherent in traditional methods. The primary objective is to create a fully automated, high-throughput system capable of accurately classifying TCM constitutions. The successful completion of this project will not only provide the first objective tool for TCM constitution analysis but will also establish a powerful framework for the early prediction and personalized management of chronic diseases, creating a new paradigm for integrated Chinese and Western medicine.
Second Affiliated Hospital of Nanchang University is the lead sponsor of 85 studies on the registry; 52 are open to participants now.
Counted across the registry records on this site, refreshed daily.
Chronic systemic disease patients and healthy subjects from the Second Affiliated Hospital of Nanchang University.
Go through the criteria one by one — yes, no or not sure — and take the list to your doctor or the study team. Kept in this browser only.
Cardiovascular and Cerebrovascular Diseases: This category includes:Hypertension: Stable hypertension without acute episodes, defined as systolic blood pressure ≥140 mmHg, diastolic blood pressure ≥90 mmHg, or currently undergoing antihypertensive treatment.Coronary Heart Disease: Diagnosed based on a history of coronary heart disease or confirmed through imaging evidence such as coronary angiography or CT angiography.
Heart Failure: Classified as (NYHA) functional class II-IV with a \<40%.Stroke: Diagnosed based on a history of ischemic or hemorrhagic stroke or confirmed through imaging evidence such as MRI or CT scans;
Diabetes Mellitus: Participants meeting at least one of the following criteria:
Fasting blood glucose ≥7.0 mmol/L (126 mg/dL),2-hour post-oral glucose tolerance test blood glucose ≥11.1 mmol/L (200 mg/dL), ≥6.5%,Random blood glucose ≥11.1 mmol/L (200 mg/dL) accompanied by typical symptoms (e.g., polydipsia, polyuria, weight loss);
Exclusion Criteria:
Underlined terms in the criteria open these too. Explained by clinicaltrials.gg, not part of the registry record. The study team decides who can take part.
The New York Heart Association’s four classes of how much heart failure limits physical activity.
Studies set their own limit — many outside heart failure leave out class III–IV, while heart failure studies may ask for a particular class. Check the class this study names.
The share of blood the heart’s main pumping chamber (the left ventricle) pushes out with each beat, measured by an echocardiogram (heart ultrasound) or a MUGA scan. About 50–70% is normal.
Cancer that has spread from where it began to other parts of the body. “Metastatic” cancer is cancer that has spread this way.
A blood test of average blood sugar over the past two to three months, given as a percentage or in mmol/mol. 6.5% (48 mmol/mol) or more is the usual threshold for diabetes, normally confirmed by a second test.
Chronic obstructive pulmonary disease: long-term lung disease that makes it hard to breathe out, including emphysema and chronic bronchitis.
From a breathing test (spirometry): how much air you can blow out in the first second. Often given as a percentage of what is expected for your age, height and sex.
NYHA class (heart failure)
The New York Heart Association’s four classes of how much heart failure limits physical activity.
Studies set their own limit — many outside heart failure leave out class III–IV, while heart failure studies may ask for a particular class. Check the class this study names.
Explained by clinicaltrials.gg, not part of the registry record. The study team decides who can take part.
LVEF (left ventricular ejection fraction)
The share of blood the heart’s main pumping chamber (the left ventricle) pushes out with each beat, measured by an echocardiogram (heart ultrasound) or a MUGA scan. About 50–70% is normal.
Explained by clinicaltrials.gg, not part of the registry record. The study team decides who can take part.
Metastases
Cancer that has spread from where it began to other parts of the body. “Metastatic” cancer is cancer that has spread this way.
Explained by clinicaltrials.gg, not part of the registry record. The study team decides who can take part.
HbA1c
A blood test of average blood sugar over the past two to three months, given as a percentage or in mmol/mol. 6.5% (48 mmol/mol) or more is the usual threshold for diabetes, normally confirmed by a second test.
Explained by clinicaltrials.gg, not part of the registry record. The study team decides who can take part.
COPD
Chronic obstructive pulmonary disease: long-term lung disease that makes it hard to breathe out, including emphysema and chronic bronchitis.
Explained by clinicaltrials.gg, not part of the registry record. The study team decides who can take part.
FEV1
From a breathing test (spirometry): how much air you can blow out in the first second. Often given as a percentage of what is expected for your age, height and sex.
Explained by clinicaltrials.gg, not part of the registry record. The study team decides who can take part.
This cohort consists of participants with a confirmed diagnosis of one or more chronic systemic diseases. These include cardiovascular diseases, malignant tumors, diabetes mellitus, and chronic respiratory diseases, as defined by the study's inclusion criteria.
Diagnostic Test: AI-based Ocular Diagnosis Model for TCM Constitutions
This cohort consists of volunteers with no history of major chronic systemic diseases. Participants are confirmed to have no conditions requiring continuous medical intervention or causing limitation of daily activities, serving as the control group for this study.
Diagnostic Test: AI-based Ocular Diagnosis Model for TCM Constitutions
AI-based Ocular Diagnosis Model for Identifying Traditional Chinese Medicine (TCM) Constitutions
AUROC of AI-based model in identifying TCM Constitutions
The area under the receiver operating characteristic of AI-based model in identifying Traditional Chinese Medicine constitutions
Time frame: Day 0
Sensitivity and specificity of AI-based model in identifying TCM Constitutions
Sensitivity and specificity of AI-based model in identifying Traditional Chinese Medicine constitutions
Time frame: Day 0
Plan to share: No
No publications or documents are linked to this record.
Started Jul 2025 (actual). Primary completion is estimated for Dec 2028, 41 months after the start.
How these figures are worked out, and which studies are left out of them.
From the registry record's own update history. This site started tracking changes on Sep 25, 2026; for anything earlier, see the record history on ClinicalTrials.gov ↗
Eligibility is decided by the study team. Share this record with your doctor or contact the team directly.
Contact study teamGet an email when the registry record changes — status, dates, results — or when someone posts here.
Sign in to followQuestions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.
Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.
Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.
Second Affiliated Hospital of Nanchang University